Cost-effectiveness analysis of interferon as adjuvant therapy in high-risk melanoma patients in Spain
J.L González-Larriba, S Serrano, M Alvarez-Mon, F Camacho, M.A Casado, J.L Dı́az-Pérez, E Dı́az-Rubio, L Fosbrook, V Guillem, J.J López-López, J.A Moreno-Nogueira, J ToribioVolume:
36
Year:
2000
Language:
english
DOI:
10.1016/s0959-8049(00)00304-x
File:
PDF, 147 KB
english, 2000